
'Recent news again highlights why you’d be well advised to heed early warnings about potentially dangerous drugs.
The first featured article reports that the US Food and Drug Administration (FDA) is now investigating a potential link between a commonly used class of diabetes drugs and pancreatic inflammation and pre-cancerous changes to the pancreas.
The FDA is also adding a heart-risk warning to the antibiotic Zithromax (azithromycin), better known as the Z-Pak.
I’ve discussed the dangers of Zithromax before, most recently in December last year, and warned of potential dangers of Januvia all the way back in 2006 — the same drug now being investigated by the FDA for a potential link to pancreatic cancer. I also published a strong warning against this class of drugs last year.'
Read more...
0 Kommentare:
Kommentar veröffentlichen